• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4612466)   Today's Articles (4057)   Subscriber (49383)
For: Groessl M, Hartinger CG, Dyson PJ, Keppler BK. CZE-ICP-MS as a tool for studying the hydrolysis of ruthenium anticancer drug candidates and their reactivity towards the DNA model compound dGMP. J Inorg Biochem 2007;102:1060-5. [PMID: 18222004 DOI: 10.1016/j.jinorgbio.2007.11.018] [Citation(s) in RCA: 87] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2007] [Revised: 10/10/2007] [Accepted: 11/29/2007] [Indexed: 01/16/2023]
Number Cited by Other Article(s)
51
Barry NPE, Sadler PJ. Dicarba-closo-dodecarborane-containing half-sandwich complexes of ruthenium, osmium, rhodium and iridium: biological relevance and synthetic strategies. Chem Soc Rev 2012;41:3264-79. [PMID: 22307021 DOI: 10.1039/c2cs15300a] [Citation(s) in RCA: 103] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
52
Blunden BM, Thomas DS, Stenzel MH. Macromolecular ruthenium complexes as anti-cancer agents. Polym Chem 2012. [DOI: 10.1039/c2py20439h] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
53
Casini A. Exploring the mechanisms of metal-based pharmacological agents via an integrated approach. J Inorg Biochem 2011;109:97-106. [PMID: 22342074 DOI: 10.1016/j.jinorgbio.2011.12.007] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2011] [Revised: 11/17/2011] [Accepted: 12/21/2011] [Indexed: 11/16/2022]
54
Bytzek AK, Boeck K, Hermann G, Hann S, Keppler BK, Hartinger CG, Koellensperger G. LC- and CZE-ICP-MS approaches for the in vivo analysis of the anticancer drug candidate sodium trans-[tetrachloridobis(1H-indazole)ruthenate(III)] (KP1339) in mouse plasma. Metallomics 2011;3:1049-55. [PMID: 21935553 DOI: 10.1039/c1mt00055a] [Citation(s) in RCA: 56] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
55
Nowak-Sliwinska P, van Beijnum JR, Casini A, Nazarov AA, Wagnières G, van den Bergh H, Dyson PJ, Griffioen AW. Organometallic Ruthenium(II) Arene Compounds with Antiangiogenic Activity. J Med Chem 2011;54:3895-902. [DOI: 10.1021/jm2002074] [Citation(s) in RCA: 212] [Impact Index Per Article: 16.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
56
Tan C, Hu S, Liu J, Ji L. Synthesis, characterization, antiproliferative and anti-metastatic properties of two ruthenium–DMSO complexes containing 2,2′-biimidazole. Eur J Med Chem 2011;46:1555-63. [DOI: 10.1016/j.ejmech.2011.01.074] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2010] [Revised: 01/20/2011] [Accepted: 01/31/2011] [Indexed: 10/18/2022]
57
Groessl M, Zava O, Dyson PJ. Cellular uptake and subcellular distribution of ruthenium-based metallodrugs under clinical investigation versus cisplatin. Metallomics 2011;3:591-9. [PMID: 21399784 DOI: 10.1039/c0mt00101e] [Citation(s) in RCA: 109] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
58
Ang WH, Casini A, Sava G, Dyson PJ. Organometallic ruthenium-based antitumor compounds with novel modes of action. J Organomet Chem 2011. [DOI: 10.1016/j.jorganchem.2010.11.009] [Citation(s) in RCA: 299] [Impact Index Per Article: 23.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
59
Adding diversity to ruthenium(II)–arene anticancer (RAPTA) compounds via click chemistry: The influence of hydrophobic chains. J Organomet Chem 2011. [DOI: 10.1016/j.jorganchem.2010.09.067] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
60
Görmen M, Pigeon P, Top S, Hillard EA, Huché M, Hartinger CG, de Montigny F, Plamont MA, Vessières A, Jaouen G. Synthesis, Cytotoxicity, and COMPARE Analysis of Ferrocene and [3]Ferrocenophane Tetrasubstituted Olefin Derivatives against Human Cancer Cells. ChemMedChem 2010;5:2039-50. [DOI: 10.1002/cmdc.201000286] [Citation(s) in RCA: 69] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
61
Vacchina V, Oguey S, Ionescu C, Bravo D, Lobinski R. Characterization of metal glycinate complexes by electrospray Q-TOF-MS/MS and their determination by capillary electrophoresis–ICP-MS: application to premix samples. Anal Bioanal Chem 2010;398:435-49. [DOI: 10.1007/s00216-010-3907-1] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2010] [Revised: 06/04/2010] [Accepted: 06/07/2010] [Indexed: 11/28/2022]
62
Ratanaphan A, Temboot P, Dyson P. In vitro Ruthenation of Human Breast Cancer Suppressor Gene 1 (BRCA1) by the Antimetastasis Compound RAPTA-C and Its Analogue CarboRAPTA-C. Chem Biodivers 2010;7:1290-302. [DOI: 10.1002/cbdv.200900288] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
63
Egger AE, Hartinger CG, Renfrew AK, Dyson PJ. Metabolization of [Ru(eta(6)-C (6)H (5)CF (3))(pta)Cl (2)]: a cytotoxic RAPTA-type complex with a strongly electron withdrawing arene ligand. J Biol Inorg Chem 2010;15:919-27. [PMID: 20364440 DOI: 10.1007/s00775-010-0654-x] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2010] [Accepted: 03/03/2010] [Indexed: 11/27/2022]
64
Bytzek AK, Reithofer MR, Galanski M, Groessl M, Keppler BK, Hartinger CG. The first example of MEEKC-ICP-MS coupling and its application for the analysis of anticancer platinum complexes. Electrophoresis 2010;31:1144-1150. [PMID: 20349510 PMCID: PMC3512080 DOI: 10.1002/elps.200900522] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
65
Ruthenium versus platinum: interactions of anticancer metallodrugs with duplex oligonucleotides characterised by electrospray ionisation mass spectrometry. J Biol Inorg Chem 2010;15:677-88. [PMID: 20213306 DOI: 10.1007/s00775-010-0635-0] [Citation(s) in RCA: 72] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2009] [Accepted: 02/03/2010] [Indexed: 01/22/2023]
66
Timerbaev AR. Inorganic species analysis by CE – An overview for 2007–2008. Electrophoresis 2010;31:192-204. [DOI: 10.1002/elps.200900397] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
67
Foteeva LS, Timerbaev AR. Application of capillary electrophoresis to the analysis of metal-containing pharmaceuticals. JOURNAL OF ANALYTICAL CHEMISTRY 2009. [DOI: 10.1134/s1061934809120028] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
68
Süss-Fink G. Arene ruthenium complexes as anticancer agents. Dalton Trans 2009;39:1673-88. [PMID: 20449402 DOI: 10.1039/b916860p] [Citation(s) in RCA: 533] [Impact Index Per Article: 35.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
69
Serum-protein interactions with anticancer Ru(III) complexes KP1019 and KP418 characterized by EPR. J Biol Inorg Chem 2009;15:131-45. [DOI: 10.1007/s00775-009-0578-5] [Citation(s) in RCA: 70] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2009] [Accepted: 07/31/2009] [Indexed: 11/25/2022]
70
Levina A, Mitra A, Lay PA. Recent developments in ruthenium anticancer drugs. Metallomics 2009;1:458-70. [PMID: 21305154 DOI: 10.1039/b904071d] [Citation(s) in RCA: 476] [Impact Index Per Article: 31.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
71
Renfrew AK, Phillips AD, Tapavicza E, Scopelliti R, Rothlisberger U, Dyson PJ. Tuning the Efficacy of Ruthenium(II)-Arene (RAPTA) Antitumor Compounds with Fluorinated Arene Ligands. Organometallics 2009. [DOI: 10.1021/om900345n] [Citation(s) in RCA: 58] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
72
Groessl M, Bytzek A, Hartinger CG. The serum protein binding of pharmacologically active gallium(III) compounds assessed by hyphenated CE-MS techniques. Electrophoresis 2009;30:2720-7. [DOI: 10.1002/elps.200800745] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
73
Electronic structural investigations of ruthenium compounds and anticancer prodrugs. J Biol Inorg Chem 2009;14:891-8. [PMID: 19350289 DOI: 10.1007/s00775-009-0501-0] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2008] [Accepted: 03/26/2009] [Indexed: 10/20/2022]
74
Auzias M, Gueniat J, Therrien B, Süss-Fink G, Renfrew AK, Dyson PJ. Arene–ruthenium complexes with ferrocene-derived ligands: Synthesis and characterization of complexes of the type [Ru(η6-arene)(NC5H4CH2NHOC-C5H4FeC5H5)Cl2] and [Ru(η6-arene)(NC3H3N(CH2)2O2C–C5H4FeC5H5)Cl2]. J Organomet Chem 2009. [DOI: 10.1016/j.jorganchem.2008.08.012] [Citation(s) in RCA: 50] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
75
Bagowski CP, You Y, Scheffler H, Vlecken DH, Schmitz DJ, Ott I. Naphthalimide gold(i) phosphine complexes as anticancer metallodrugs. Dalton Trans 2009:10799-805. [DOI: 10.1039/b912378d] [Citation(s) in RCA: 77] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
76
Hartinger CG, Jakupec MA, Zorbas-Seifried S, Groessl M, Egger A, Berger W, Zorbas H, Dyson PJ, Keppler BK. KP1019, a new redox-active anticancer agent--preclinical development and results of a clinical phase I study in tumor patients. Chem Biodivers 2008;5:2140-2155. [PMID: 18972504 DOI: 10.1002/cbdv.200890195] [Citation(s) in RCA: 649] [Impact Index Per Article: 40.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
77
Groessl M, Hartinger CG, Połeć-Pawlak K, Jarosz M, Dyson PJ, Keppler BK. Elucidation of the interactions of an anticancer ruthenium complex in clinical trials with biomolecules utilizing capillary electrophoresis hyphenated to inductively coupled plasma-mass spectrometry. Short communication. Chem Biodivers 2008;5:1609-1614. [PMID: 18729095 DOI: 10.1002/cbdv.200890148] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
78
Hydrolysis study of the bifunctional antitumour compound RAPTA-C, [Ru(η6-p-cymene)Cl2(pta)]. J Inorg Biochem 2008;102:1743-8. [DOI: 10.1016/j.jinorgbio.2008.05.004] [Citation(s) in RCA: 98] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2008] [Revised: 05/08/2008] [Accepted: 05/09/2008] [Indexed: 11/21/2022]
79
Dorcier A, Hartinger CG, Scopelliti R, Fish RH, Keppler BK, Dyson PJ. Studies on the reactivity of organometallic Ru-, Rh- and Os-pta complexes with DNA model compounds. J Inorg Biochem 2007;102:1066-76. [PMID: 18086499 DOI: 10.1016/j.jinorgbio.2007.10.016] [Citation(s) in RCA: 87] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2007] [Revised: 10/10/2007] [Accepted: 10/31/2007] [Indexed: 10/22/2022]
PrevPage 2 of 2 12Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA